A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

SHR-A2102

DRUG

SHR-A2102 ; Adebrelimab injection

SHR-A2102 + Adebrelimab injection

Trial Locations (1)

RECRUITING

Peking University Cancer Hospital, Beijing

All Listed Sponsors

lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY